Autoantibodies against aldehyde-modified collagen type IV are associated with risk of development of myocardial infarction

Vallejo J, Dunér P, Fredrikson GN, Nilsson J, Bengtsson E

J Intern Med 282 (6) 496-507 [2017-12-00; online 2017-09-25]

Clinical Biomarkers [Service]

QC bibliography QC xrefs

DOI 10.1111/joim.12659

Crossref 10.1111/joim.12659